Northern Trust Company of Connecticut’s Clovis Oncology, Inc. CLVS Stock Holding History

Northern Trust Company of Connecticut’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$184K	Hold	3,058	–	–	﹤0.01%	1795
2013 Q3	$186K	Hold	3,058	–	–	﹤0.01%	1760
2013 Q2	$205K	Buy	+3,058	New	+$138K	﹤0.01%	1693

Other funds holding CLVS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Company of Connecticut's CLVS Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its Clovis Oncology, Inc. (CLVS) position steady in Q4 2013 at 3,058 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Northern Trust Company of Connecticut first reported a position in CLVS in Q2 2013 and has held it in 3 quarters since. The position peaked at $205K in Q2 2013. 112 funds tracked by Wall St. Rank hold CLVS as of Q4 2013.

Northern Trust Company of Connecticut held 3,058 shares of Clovis Oncology, Inc. worth $184K as of Q4 2013.
Northern Trust Company of Connecticut left its Clovis Oncology, Inc. share count unchanged in Q4 2013.
Clovis Oncology, Inc. made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1795 holding.
Northern Trust Company of Connecticut first reported a position in Clovis Oncology, Inc. in Q2 2013 and has held it in 3 quarters since.
Northern Trust Company of Connecticut's Clovis Oncology, Inc. position peaked at $205K in Q2 2013.
112 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.